Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|October 31, 2019
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: a preliminary reportEsperanza Naredo, Javier Pascau, Nemanja Damjanov, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 19, 2009
Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detectionMaría del Rosario Brunetto, Yaritza Contreras, Sabrina Clavijo, et al.
Neuroscience|November 5, 2019
Plasma Membrane Affiliated AMPA GluA1 in Estrogen Receptor β-containing Paraventricular Hypothalamic Neurons Increases Following Hypertension in a Mouse Model of Post-menopauseAstrid C Ovalles, Natalina H Contoreggi, Jose Marques-Lopes, et al.
Archives of Dermatological Research|September 9, 2008
Antigens from Leishmania amastigotes induced clinical remission of psoriasisJ A O'Daly, R Lezama, P J Rodriguez, et al.
Cureus|December 18, 2023
Prognostic Factors Associated With Overall Survival in Breast Cancer Patients With Metastatic Spinal DiseaseGervith Reyes Soto, Bernardo Cacho-Díaza, Carlos Bravo-Reynab, et al.
Cognitive Behaviour Therapy|September 23, 2025
Preference for the modality of psychosocial treatment for anxiety in adults with comorbid anxiety and chronic musculoskeletal painAnnell Ovalles, E Marie Parsons, Margot Steinberg, et al.
Rheumatology International|August 10, 2019
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR studyAntonio Gomez-Centeno, Esteban Rubio-Romero, Juan Gabriel Ovalles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2018
High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractionsGorka Nagore, Jose Luis Lopez Guerra, Evita Krumina, et al.
Plos One|April 7, 2016
Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory StudyIgnacio Ortea, Bernd Roschitzki, Rosario López-Rodríguez, et al.
Clinical and Experimental Rheumatology|August 30, 2017
An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patientsLina Martínez-Estupiñán, Diana Hernández-Flórez, Iustina Janta, et al.
Pageof 7